Equitable Holdings, Inc. Astrazeneca PLC Transaction History

Equitable Holdings, Inc.

$9.13 Billion
Q2 2024

A detailed history of Equitable Holdings, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Equitable Holdings, Inc. holds 6,083 shares of AZN stock, worth $476,116. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,083

Previous 4,761 27.77%

Holding current value

$476,116

Previous $322,000 47.2%

% of portfolio

0.01%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $88,322 - $106,857	1,322 Added 27.77%	6,083 $474,000
Q1 2024 May 14, 2024	BUY	$61.03 - $69.57 $24,045 - $27,410	394 Added 9.02%	4,761 $322,000
Q4 2023 Feb 12, 2024	SELL	$61.89 - $69.28 $16,277 - $18,220	-263 Reduced 5.68%	4,367 $294,000
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $28,404 - $31,404	438 Added 10.45%	4,630 $313,000
Q2 2023 Aug 15, 2023	SELL	$69.91 - $75.81 $1,328 - $1,440	-19 Reduced 0.45%	4,192 $300,000
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $19,071 - $21,623	302 Added 7.73%	4,211 $292,000
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $3,577 - $4,649	-66 Reduced 1.66%	3,909 $265,000
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $901 - $2,307	-17 Reduced 0.43%	3,975 $218,000
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $8,829 - $10,599	149 Added 3.88%	3,992 $264,000
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $2,674 - $3,221	48 Added 1.26%	3,843 $255,000
Q4 2021 Feb 11, 2022	SELL	$54.02 - $63.83 $2,160 - $2,553	-40 Reduced 1.04%	3,795 $221,000
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $213,072 - $233,129	3,835 New	3,835 $230,000

Others Institutions Holding AZN

# of Institutions

1,332

Shares Held

490M

Call Options Held

4.99M

Put Options Held

3.19M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $243B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitable Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Equitable Holdings, Inc. with notifications on news.

Account

Equitable Holdings, Inc. Astrazeneca PLC Transaction History